Mycronic AB (MYCR) AI Stock Analysis

• Market Cap: kr37.07B
• Dividend Yield: 0.53%
• Average Volume (3M): 185.69K
• Price to Earnings (P/E): 20.4
• Beta (1Y): 1.07
• Revenue Growth: 21.51%
• EPS Growth: 35.67%
• Country: SE
• Employees: 2,318
• Sector: Technology
• Sector Strength: 84
• Industry: Industrial - Machinery
• EPS (TTM): 3.17
• Shares Outstanding: 195,833,020
• 10 Day Avg. Volume: 164,854
• 30 Day Avg. Volume: 185,685
• PEG Ratio: 2.69
• Price to Book (P/B): 5.43
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 28.45
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 63 Neutral
• Price Target: ―

Mycronic AB shows strong financial fundamentals, which are a significant strength. However, the technical indicators suggest potential short-term weakness, impacting the overall score. The valuation is fair, supporting a moderate overall stock score. The zero EBIT in 2024 warrants attention but does not overshadow the company's financial stability.

Mycronic AB Business Overview & Revenue Model

Company Description

Mycronic AB (publ), together with its subsidiaries, develops, manufactures, and sells production equipment for electronics industry in Sweden, rest of Europe, the United States, other Americas, China, South Korea, rest of Asia, and internationally. The company operates through four segments: Pattern Generators, High Flex, High Volume, and Global Technologies. The Pattern Generators segment develops, manufactures, and markets mask writers and measuring machines for production of advanced photomasks for manufacturing of screens for TVs, cars, mobile phones, tablets, and computers, as well as the semiconductor components. The High Flex segment develops, manufactures, and markets surface mount technology (SMT) and inspection equipment for flexible printed circuit board (PCBs) assembly. This segment offers MYPro Line, which integrates advanced jet printing and dispensing, pick-and-place, advanced process control solutions, and 3D inspection systems; MYTower material handling systems; and MYSmart dispensing and coating solutions. The High Volume segment develops, manufactures, and markets equipment for dispensing and conformal coating of circuit boards for manufacturers of mobile phones, tablets, computers, and electronics for electric vehicles, as well as automated screen printers. The Global Technologies segment offers die-bonding services for microelectronics and optoelectronic applications; advanced electrical measurement of bare board PCBs and substrates; flying probe test system, an automated electrical measurement system for low to mid quantities and complex boards; and grid test systems for volume bare board verification. It sells its products through agents and distributors. The company serves industrial, aerospace, defense, automotive, energy, medical, and telecom sectors. The company was formerly known as Micronic Mydata AB (publ) and changed its name to Mycronic AB (publ) in June 2014. Mycronic AB (publ) is headquartered in Täby, Sweden.

How the Company Makes Money

Mycronic AB generates revenue primarily through the sale of its production equipment and solutions to electronics manufacturers. The company's key revenue streams include the Pattern Generators segment, where it supplies mask writers used in the production of advanced displays, and the Assembly Solutions segment, which provides high-precision assembly equipment for electronic components. Mycronic also earns from service contracts, spare parts, and software upgrades for its equipment. Strategic partnerships with major electronics manufacturers and continuous innovation in technology contribute significantly to its earnings.

Mycronic AB Financial Statement Overview

Summary

Mycronic AB demonstrates strong financial performance with solid revenue growth, robust profit margins, and a healthy balance sheet with no debt. The company's cash flow is impressive, showing efficient cash management. The only concern is the zero EBIT in 2024, but overall, the financial health is strong.

Income Statement

Mycronic AB shows a strong income statement with consistent revenue growth, evidenced by a 23.7% increase from 2023 to 2024. Gross profit margin is robust at 52.7% for 2024, though EBIT margin dropped due to an EBIT of zero. Net profit margin improved to 23.8% in 2024, indicating solid profitability. The absence of EBIT in 2024 is a concern, but the overall financial health remains strong.

Balance Sheet

The balance sheet is very healthy with no debt in 2024, resulting in an excellent debt-to-equity ratio. Stockholders' equity has been increasing steadily, and the equity ratio is strong at 62.8%, reflecting financial stability and low leverage. The company has ample cash reserves, enhancing its financial flexibility.

Cash Flow

Cash flow is solid, with a substantial increase in free cash flow from 2023 to 2024, growing by approximately 32.5%. The company converts operating cash flow to net income effectively, indicating strong cash generation capabilities. The free cash flow to net income ratio is excellent, showcasing efficient cash management.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
7.51B	7.06B	5.71B	5.12B	4.63B	3.88B
	Gross Profit
4.05B	3.72B	2.72B	2.29B	2.28B	2.08B
	EBIT
2.23B	2.01B	1.21B	894.00M	1.05B	904.00M
	EBITDA
2.24B	2.32B	1.39B	1.11B	1.15B	1.06B
	Net Income Common Stockholders
1.81B	1.68B	998.00M	741.00M	828.00M	694.00M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
2.99B	3.01B	2.14B	1.27B	683.00M	1.30B
	Total Assets
10.53B	10.41B	8.34B	7.34B	6.14B	5.32B
	Total Debt
0.00	0.00	228.00M	270.00M	243.00M	264.00M
	Net Debt
-2.99B	-2.79B	-1.91B	-1.00B	-440.00M	-1.04B
	Total Liabilities
3.47B	3.84B	3.06B	2.64B	2.14B	1.94B
	Stockholders Equity
7.02B	6.53B	5.25B	4.66B	3.96B	3.36B
Cash Flow		Free Cash Flow
1.34B	1.64B	1.41B	712.00M	908.00M	991.00M
	Operating Cash Flow
1.38B	1.87B	1.61B	853.00M	998.00M	1.13B
	Investing Cash Flow
-616.00M	-500.00M	-195.00M	67.00M	-1.22B	-150.00M
	Financing Cash Flow
-554.00M	-552.00M	-447.00M	-382.00M	-437.00M	-288.00M

Mycronic AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 189.50
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:MYCR, the sentiment is Negative. The current price of 189.5 is below the 20-day moving average (MA) of 195.44, below the 50-day MA of 191.85, and below the 200-day MA of 200.30, indicating a bearish trend. The MACD of -1.50 indicates Positive momentum. The RSI at 41.30 is Neutral, neither overbought nor oversold. The STOCH value of 24.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:MYCR.

Mycronic AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ALIG	77 Outperform	kr15.56B	22.70	9.04%	2.07%	0.13%	29.88%
AQ	76 Outperform	kr16.78B	25.94	15.07%	0.87%	-3.59%	-1.67%
TROAX	67 Neutral	kr9.40B	27.49	16.33%	2.26%	2.59%	-11.50%
MYCR	63 Neutral	kr37.07B	20.36	28.32%	0.53%	21.51%	35.67%
BEIJ.B	63 Neutral	kr75.58B	32.75	10.11%	0.87%	13.64%	-4.83%
Sector *	62 Neutral	$11.93B	10.60	-7.51%	3.00%	7.40%	-8.09%
FAG	58 Neutral	kr7.94B	27.54	3.84%	3.09%	-5.29%	-44.98%